RBP4 and fatty liver disease: Notably, there is no evidence of increased hepatic de novo lipogenesis or decreased hepatic free fatty acid oxidation and very-low-density lipoprotein secretion, suggesting that RBP4-induced liver steatosis mainly arises from the primary effects occurring in AT.